Agendia Announces Launch of ColoPrint for Colon Cancer Prognosis and Prediction
Agendia’s Microarray-based Gene Expression Profile Provides Critical Additional Information for Read More
Agendia Raises $65 Million in a Private Round of Equity Financing
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, May 31, 2012 – Read More
Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
AMSTERDAM, THE NETHERLANDS, and IRVINE, CA, May 29, 2012 – Read More
RASTER: First-Ever Prospective Diagnostic Study in Breast Cancer
RASTER Five-Year Follow-Up Data Indicates Chemotherapy May Be Safely Withheld Read More
Agendia Wins 2011 Scrip Award for “Best Partnership Alliance”
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, FEBRUARY 29, 2012 – Read More
Agendia Presents Broad Array of Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO 2010 Annual Meeting
HUNTINGTON BEACH, CA, and AMSTERDAM, THE NETHERLANDS, June 4, 2010 -- Read More
Agendia to Present at BioCentury’s Future Leaders in the Biotech Industry Conference
HUNTINGTON BEACH, CA, and AMSTERDAM, THE NETHERLANDS, March 24, 2009 Read More
